DOWNLOAD FULL SERVICE LIST
Driving innovation and serving industry end-to-end
From innovative GARD® sensitization testing to biological evaluation of Medical Devices, we offer both customized studies and standard regulatory in vitro toxicity testing and advisory services. Rely on our expert analysis and personalized guidance to confidently advance every stage of your project.
Skin sensitization
- Hazard assessment: GARD®skin OECD 442E, 497
- Quantitative potency assessment: GARD®skin Dose-Response
- Adaptation for extractable medical devices and solid materials: GARD®skin Medical Device ISO 10993-10
Respiratory sensitization
Biological Safety
Substance-Based Medical Devices
Advisory
Skin
- Skin Corrosion OECD 431
- Skin Irritation OECD 439
- Skin Sensitization:
- Key Event 1 | OECD 442C: DPRA, ADRA
- Key Event 2 | OECD 442D: EpiSensA, KeratinoSens*
- Key Event 3 | OECD 442E: GARD®skin
- In silico predictions*
- Skin Absorption: OECD 428*
Eye
Phototoxicity
Genotoxicity
*Service delivered by SenzaGen’s group companies VitroScreen and ToxHub.
**Service delivered by partner CROs.
Industries
Area of Expertise
Advancing Skin Sensitization Testing
With high performance and broad applicability, SenzaGen’s GARD technology, powered by genomics and machine learning, is bringing new opportunities to the field of Skin Sensitization Testing.
Meet Your Deadlines with Confidence
- +25 years of in vitro science expertise
- Specialized in difficult-to-test samples
- Personal support throughout your project
